\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ laboratory\\ data\\:\ \(0\)\
\-\ wbc\\:\\ 5\\.4\\,\\ hgb\\:\\ 11\\.0\\,\\ hct\\:\\ 33\\.6\\,\\ plts\\:\\ 309\\.\ \(0\)\
\-\ further\\ in\\ the\\ hospitalization\\:\ \(0\)\
\-\ ldh\\:\\ 506\\ u\\/l\ \(0\)\
\-\ gram\\ stain\\:\\ few\\ rbcs\\,\\ no\\ organisms\\ noted\\.\ \(0\)\
\-\ afb\\:\\ negative\ \(0\)\
\-\ pneumocystis\\ direct\\ fluorescent\\ antibody\\ \\(dfa\\)\\:\\ negative\\ \ \(0\)\
\-\ c\\.\\ neoformans\\:\\ negative\ \(0\)\
\-\ legionella\\:\\ negative\ \(0\)\
\-\ s\\.\\ pneumonia\\:\\ negative\ \(0\)\
\-\ hiv\\:\\ positive\ \(0\)\
\-\ cd4\\/cd8\\ ratio\\:\\ 0\\.55\\ l\\ \\(0\\.79\\-4\\.39\\)\ \(0\)\
\-\ abs\\ cd3\\/cd4\\:\\ 144\\ l\\ \\(414\\-1293\\ cell\\/ul\\)\ \(0\)\
\-\ abs\\ cd3\\:\\ 413\\ l\\ \\(690\\-2540\\ cell\\/ul\\)\ \(0\)\
\-\ abs\\ cd19\\+\\:\\ 51\\ l\\ \\(90\\-660\\ cell\\/ul\\)\ \(0\)\
\-\ the\\ lingular\\ biopsy\\ specimen\\ demonstrated\\ diffuse\\ alveolar\\ damage\\,\\ with\\ an\\ organizing\\ fibrosing\\ pattern\\.\\ \\ the\\ anterior\\ segment\\ of\\ the\\ left\\ upper\\ lobe\\ specimen\\ revealed\\ marked\\ interstitial\\ fibrosis\\,\\ focal\\ type\\ ii\\ pneumocyte\\ hyperplasia\\,\\ squamous\\ metaplasia\\,\\ and\\ scattered\\ residual\\ alveoli\\ consistent\\ with\\ organizing\\ to\\ fibrosing\\ pattern\\ of\\ diffuse\\ alveolar\\ damage\\.\\ \\ the\\ typical\\ histologic\\ findings\\ of\\ pcp\\ consist\\ of\\ proliferation\\ of\\ type\\ ii\\ pneumocytes\\,\\ diffuse\\ alveolar\\ damage\\,\\ granulomatous\\ inflammation\\,\\ and\\ cyst\\ formation\\.\ \(0\)\
\-\ open\\ lung\\ biopsy\\ demonstrated\\ the\\ histologic\\ findings\\ of\\ pneumocystis\\ jiroveci\\,\\ and\\ the\\ gms\\ stain\\ was\\ positive\\,\\ confirming\\ the\\ suspected\\ diagnosis\\ of\\ pneumocystis\\ jiiroveci\\ pneumonia\\.\ \(0\)\
\-\ admission\\ radiography\\:\\ \\ pa\\ chest\\ radiograph\\ reveals\\ a\\ right\\ subclavian\\ central\\ venous\\ catheter\\ with\\ hypoinflated\\ lung\\ volumes\\ and\\ increased\\ bibasilar\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ contrast\\ enhanced\\ ct\\ on\\ admission\\:\\ \\ diffuse\\ multilobar\\ ground\\-glass\\ opacities\\ with\\ sharp\\ transitions\\ between\\ normal\\ and\\ abnormal\\ lung\\,\\ with\\ interstitial\\ thickening\\ in\\ a\\ predominately\\ lower\\-lobe\\ distribution\\.\ \(0\)\
\-\ hospital\\ day\\ 2\\:\\ \\ ap\\ chest\\ radiograph\\ demonstrates\\ a\\ stable\\ right\\ subclavian\\ venous\\ catheter\\,\\ with\\ bibasilar\\ reticulonodular\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ hospital\\ day\\ 6\\:\\ ap\\ chest\\ radiograph\\ from\\ hospital\\ day\\ 6\\,\\ reveals\\ that\\ the\\ patient\\ has\\ been\\ intubated\\,\\ and\\ has\\ developed\\ a\\ spontaneous\\ pneumomediastinum\\ with\\ extensive\\ subcutaneous\\ emphysema\\ surrounding\\ the\\ neck\\.\\ \\ there\\ is\\ no\\ pneumothorax\\.\\ \\ there\\ are\\ continued\\ bibasilar\\ reticulonodular\\ ground\\ glass\\ opacities\\.\ \(0\)\
\-\ ap\\ chest\\ radiograph\\ from\\ hospital\\ day\\ 6\\,\\ obtained\\ later\\ in\\ the\\ day\\ secondary\\ to\\ new\\ respiratory\\ distress\\,\\ reveals\\ that\\ the\\ patient\\ has\\ developed\\ a\\ significant\\ left\\ sided\\ pneumothorax\\,\\ with\\ persistent\\ pneumomediastinum\\,\\ bibasilar\\ ground\\-glass\\ reticulonodular\\ opacities\\,\\ and\\ subcutaneous\\ emphysema\\ surrounding\\ the\\ base\\ of\\ the\\ neck\\.\\ \\ the\\ patient\\â\\€\\™s\\ support\\ devices\\ are\\ stable\\ when\\ compared\\ to\\ the\\ prior\\ studies\\.\ \(0\)\
\-\ on\\ hospital\\ day\\ 10\\ the\\ patient\\ experienced\\ worsening\\ respiratory\\ distress\\,\\ and\\ an\\ unenhanced\\ ct\\ of\\ the\\ chest\\ was\\ performed\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ aortic\\ arch\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ is\\ a\\ small\\ right\\-sided\\ pleural\\ effusion\\,\\ with\\ persistent\\ ground\\-glass\\ opacities\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ hila\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ are\\ persistent\\ ground\\-glass\\ opacities\\ with\\ focal\\ areas\\ of\\ consolidation\\.\ \(0\)\
\-\ an\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ right\\ hemidiaphragm\\ demonstrates\\ continued\\ pneumomediastinum\\,\\ and\\ a\\ left\\-sided\\ pneumothorax\\.\\ \\ there\\ are\\ persistent\\ ground\\-glass\\ opacities\\ with\\ focal\\ areas\\ of\\ consolidation\\,\\ and\\ a\\ small\\ right\\-sided\\ pleural\\ effusion\\.\ \(0\)\
\-\ pneumocystis\\ jiroveci\\ \\(p\\.\\ carinii\\)\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ pneumocystis\\ jiroveci\\ pneumonia\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cmv\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ lymphocytic\\ interstitial\\ pneumonia\\.\ \(0\)\
\-\ 60\\ year\\ old\\ male\\ with\\ tachypnea\\ and\\ tachycardia\\ with\\ high\\ clinical\\ concern\\ for\\ pulmonary\\ embolus\\.\ \(1\)\
\-\ this\\ case\\ demonstrates\\ typical\\ radiographic\\ findings\\ of\\ pcp\\,\\ with\\ symmetric\\ bilateral\\ lower\\ lobe\\ reticulonodular\\ opacities\\,\\ complicated\\ by\\ pneumomediastinum\\ followed\\ by\\ the\\ development\\ of\\ pneumothorax\\.\\ \\ additionally\\,\\ the\\ bal\\ was\\ negative\\,\\ necessitating\\ open\\ lung\\ biopsy\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ opacities\\:\\ 0\\.2827943838357123\ \(0\)\
\-\ glass\\:\\ 0\\.26484604715974197\ \(0\)\
\-\ ground\\:\\ 0\\.25630071150740996\ \(0\)\
\-\ pneumomediastinum\\:\\ 0\\.216710956876444\ \(0\)\
\-\ pneumocystis\\:\\ 0\\.20702485629807515\ \(0\)\
\-\ the\\:\\ 0\\.17730701896857876\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.17209573057340705\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.16113920418043692\ \(0\)\
\-\ pneumonia\\:\\ 0\\.15585989069922304\ \(0\)\
\-\ bibasilar\\:\\ 0\\.14881379062987768\ \(0\)\
\-\ abs\\:\\ 0\\.13888019976681326\ \(0\)\
\-\ jiroveci\\:\\ 0\\.13621211347674123\ \(0\)\
\-\ sided\\:\\ 0\\.12701999456466462\ \(0\)\
\-\ day\\:\\ 0\\.12578225552746036\ \(0\)\
\-\ negative\\:\\ 0\\.12224965720535697\ \(0\)\
\-\ hospital\\:\\ 0\\.12154892510375948\ \(0\)\
\-\ continued\\:\\ 0\\.10786540419854763\ \(0\)\
\-\ alveolar\\:\\ 0\\.10362523526902015\ \(0\)\
\-\ of\\:\\ 0\\.10304842941193788\ \(0\)\
\-\ persistent\\:\\ 0\\.1014296832188756\ \(0\)\
\-\ damage\\:\\ 0\\.09611276681527872\ \(0\)\
\-\ cd3\\:\\ 0\\.09258679984454217\ \(0\)\
\-\ with\\:\\ 0\\.09022125072096188\ \(0\)\
\-\ interstitial\\:\\ 0\\.08950599773728433\ \(0\)\
\-\ and\\:\\ 0\\.08840837800029634\ \(0\)\
\-\ chest\\:\\ 0\\.08686033023394521\ \(0\)\
\-\ organizing\\:\\ 0\\.0866924509087484\ \(0\)\
\-\ radiograph\\:\\ 0\\.08574180997199986\ \(0\)\
\-\ fibrosing\\:\\ 0\\.08458866671261141\ \(0\)\
\-\ demonstrates\\:\\ 0\\.08267051180665205\ \(0\)\
\-\ diffuse\\:\\ 0\\.08255695175796357\ \(0\)\
\-\ lung\\:\\ 0\\.08008044006309856\ \(0\)\
\-\ reveals\\:\\ 0\\.07510423421771366\ \(0\)\
\-\ histologic\\:\\ 0\\.07363735241416425\ \(0\)\
\-\ pcp\\:\\ 0\\.07363735241416425\ \(0\)\
\-\ stain\\:\\ 0\\.07159577250347353\ \(0\)\
\-\ ap\\:\\ 0\\.0708836358665079\ \(0\)\
\-\ specimen\\:\\ 0\\.07013320142934434\ \(0\)\
\-\ biopsy\\:\\ 0\\.06920820305032808\ \(0\)\
\-\ there\\:\\ 0\\.06547582020713771\ \(0\)\
\-\ emphysema\\:\\ 0\\.06457333582635694\ \(0\)\
\-\ image\\:\\ 0\\.06314328228282207\ \(0\)\
\-\ an\\:\\ 0\\.06292518006742283\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.06269805151295611\ \(0\)\
\-\ subclavian\\:\\ 0\\.061598280023894524\ \(0\)\
\-\ consolidation\\:\\ 0\\.06083719980557172\ \(0\)\
\-\ level\\:\\ 0\\.059640350678024076\ \(0\)\
\-\ focal\\:\\ 0\\.05905752455186483\ \(0\)\
\-\ catheter\\:\\ 0\\.05851053328559804\ \(0\)\
\-\ lobe\\:\\ 0\\.05705715077932813\ \(0\)\
\-\ axial\\:\\ 0\\.05703164112031294\ \(0\)\
\-\ left\\:\\ 0\\.0561332106265715\ \(0\)\
\-\ admission\\:\\ 0\\.05491832616977893\ \(0\)\
\-\ right\\:\\ 0\\.05455670477669158\ \(0\)\
\-\ open\\:\\ 0\\.054414993608319154\ \(0\)\
\-\ distress\\:\\ 0\\.05302468247779404\ \(0\)\
\-\ pneumocyte\\:\\ 0\\.05263177046721394\ \(0\)\
\-\ pneumocytes\\:\\ 0\\.05263177046721394\ \(0\)\
\-\ jiiroveci\\:\\ 0\\.05263177046721394\ \(0\)\
\-\ transitions\\:\\ 0\\.05263177046721394\ \(0\)\
\-\ respiratory\\:\\ 0\\.052358210972101464\ \(0\)\
\-\ stable\\:\\ 0\\.05206754404102556\ \(0\)\
\-\ ii\\:\\ 0\\.051896594736471215\ \(0\)\
\-\ typical\\:\\ 0\\.050869038117930684\ \(0\)\
\-\ 506\\:\\ 0\\.050292466488236466\ \(0\)\
\-\ fluorescent\\:\\ 0\\.050292466488236466\ \(0\)\
\-\ multilobar\\:\\ 0\\.050292466488236466\ \(0\)\
\-\ are\\:\\ 0\\.049952831826968885\ \(0\)\
\-\ pleural\\:\\ 0\\.04955027085738942\ \(0\)\
\-\ pattern\\:\\ 0\\.049142174088275696\ \(0\)\
\-\ effusion\\:\\ 0\\.04887791367597332\ \(0\)\
\-\ developed\\:\\ 0\\.04883445273191665\ \(0\)\
\-\ findings\\:\\ 0\\.04872861859962071\ \(0\)\
\-\ dfa\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ neoformans\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ 413\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ gms\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ hypoinflated\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ bal\\:\\ 0\\.04863270390124856\ \(0\)\
\-\ venous\\:\\ 0\\.04699392406830385\ \(0\)\
\-\ has\\:\\ 0\\.04509828620343469\ \(0\)\
\-\ areas\\:\\ 0\\.04468850243458331\ \(0\)\
\-\ type\\:\\ 0\\.04415584477396171\ \(0\)\
\-\ plts\\:\\ 0\\.04395409594329361\ \(0\)\
\-\ legionella\\:\\ 0\\.04395409594329361\ \(0\)\
\-\ metaplasia\\:\\ 0\\.04395409594329361\ \(0\)\
\-\ alveoli\\:\\ 0\\.04395409594329361\ \(0\)\
\-\ surrounding\\:\\ 0\\.04389846160454046\ \(0\)\
\-\ positive\\:\\ 0\\.04337324885482026\ \(0\)\
\-\ carinii\\:\\ 0\\.0433462254543742\ \(0\)\
\-\ patient\\:\\ 0\\.04281711677286686\ \(0\)\
\-\ necessitating\\:\\ 0\\.04279633970984341\ \(0\)\
\-\ lingular\\:\\ 0\\.042294333356305704\ \(0\)\
\-\ hila\\:\\ 0\\.042294333356305704\ \(0\)\
\-\ 144\\:\\ 0\\.04140497125961503\ \(0\)\
\-\ devices\\:\\ 0\\.0406345707693178\ \(0\)\
\-\ demonstrated\\:\\ 0\\.04045236623639707\ \(0\)\
\-\ neck\\:\\ 0\\.04026507663677084\ \(0\)\
\-\ afb\\:\\ 0\\.03995502937732823\ \(0\)\
\-\ rbcs\\:\\ 0\\.03964309213952262\ \(0\)\
\-\ volumes\\:\\ 0\\.03854081165563877\ \(0\)\
\-\ antibody\\:\\ 0\\.03761572539835076\ \(0\)\
\-\ consist\\:\\ 0\\.03740590469364965\ \(0\)\
\-\ at\\:\\ 0\\.037292645019453806\ \(0\)\
\-\ predominately\\:\\ 0\\.03720344765746942\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.03700785490943134\ \(0\)\
\-\ confirming\\:\\ 0\\.036818676207082124\ \(0\)\
\-\ cmv\\:\\ 0\\.036818676207082124\ \(0\)\
\-\ hospitalization\\:\\ 0\\.03628573447914385\ \(0\)\
\-\ unenhanced\\:\\ 0\\.03595596281136285\ \(0\)\
\-\ ldh\\:\\ 0\\.035797886251736764\ \(0\)\
\-\ organisms\\:\\ 0\\.035494161732048064\ \(0\)\
\-\ proliferation\\:\\ 0\\.03534809232244344\ \(0\)\
\-\ embolus\\:\\ 0\\.03520562993609034\ \(0\)\
\-\ gram\\:\\ 0\\.03506660071467217\ \(0\)\
\-\ intubated\\:\\ 0\\.034798206577912646\ \(0\)\
\-\ tachypnea\\:\\ 0\\.034798206577912646\ \(0\)\
\-\ was\\:\\ 0\\.0344093735571707\ \(0\)\
\-\ hemidiaphragm\\:\\ 0\\.03429620022437494\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03412160427922834\ \(0\)\
\-\ small\\:\\ 0\\.033953150674263216\ \(0\)\
\-\ lower\\:\\ 0\\.03363506069105253\ \(0\)\
\-\ radiography\\:\\ 0\\.03361665883238537\ \(0\)\
\-\ tachycardia\\:\\ 0\\.03361665883238537\ \(0\)\
\-\ ratio\\:\\ 0\\.03300878834346596\ \(0\)\
\-\ to\\:\\ 0\\.03291068933758705\ \(0\)\
\-\ hiv\\:\\ 0\\.03254698726415118\ \(0\)\
\-\ sharp\\:\\ 0\\.03237214256545564\ \(0\)\
\-\ data\\:\\ 0\\.03228666791317847\ \(0\)\
\-\ hgb\\:\\ 0\\.031956896245397465\ \(0\)\
\-\ support\\:\\ 0\\.031956896245397465\ \(0\)\
\-\ 51\\:\\ 0\\.03142159820396804\ \(0\)\
\-\ experienced\\:\\ 0\\.03127735485340789\ \(0\)\
\-\ hct\\:\\ 0\\.031206563370124958\ \(0\)\
\-\ complicated\\:\\ 0\\.031206563370124958\ \(0\)\
\-\ confirm\\:\\ 0\\.030799140011947262\ \(0\)\
\-\ concern\\:\\ 0\\.030178172052016117\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.030004206103379834\ \(0\)\
\-\ residual\\:\\ 0\\.02994736393420099\ \(0\)\
\-\ squamous\\:\\ 0\\.029617592266419992\ \(0\)\
\-\ granulomatous\\:\\ 0\\.02925526664279902\ \(0\)\
\-\ direct\\:\\ 0\\.029009721777500577\ \(0\)\
\-\ scattered\\:\\ 0\\.02863737107142166\ \(0\)\
\-\ spontaneous\\:\\ 0\\.02863737107142166\ \(0\)\
\-\ that\\:\\ 0\\.028564234375830153\ \(0\)\
\-\ symmetric\\:\\ 0\\.028203374544730524\ \(0\)\
\-\ by\\:\\ 0\\.02795179447694338\ \(0\)\
\-\ few\\:\\ 0\\.027917902644629674\ \(0\)\
\-\ distribution\\:\\ 0\\.027917902644629674\ \(0\)\
\-\ arch\\:\\ 0\\.027917902644629674\ \(0\)\
\-\ fibrosis\\:\\ 0\\.02757047393627911\ \(0\)\
\-\ development\\:\\ 0\\.027207496804159577\ \(0\)\
\-\ segment\\:\\ 0\\.02717242415206081\ \(0\)\
\-\ additionally\\:\\ 0\\.027102912064171272\ \(0\)\
\-\ suspected\\:\\ 0\\.02696635104963691\ \(0\)\
\-\ compared\\:\\ 0\\.026606666503426628\ \(0\)\
\-\ inflammation\\:\\ 0\\.026450303721773313\ \(0\)\
\-\ from\\:\\ 0\\.02614166647354743\ \(0\)\
\-\ formation\\:\\ 0\\.026091466836335148\ \(0\)\
\-\ aortic\\:\\ 0\\.025434519058965342\ \(0\)\
\-\ extensive\\:\\ 0\\.0253574208047189\ \(0\)\
\-\ pa\\:\\ 0\\.025256200076833636\ \(0\)\
\-\ worsening\\:\\ 0\\.025132121455911496\ \(0\)\
\-\ ct\\:\\ 0\\.025059013739375115\ \(0\)\
\-\ enhanced\\:\\ 0\\.025058935271544933\ \(0\)\
\-\ base\\:\\ 0\\.025034744739237887\ \(0\)\
\-\ marked\\:\\ 0\\.024891693605141752\ \(0\)\
\-\ 60\\:\\ 0\\.02461581155882641\ \(0\)\
\-\ in\\:\\ 0\\.024561527244620865\ \(0\)\
\-\ radiographic\\:\\ 0\\.024417226365958326\ \(0\)\
\-\ studies\\:\\ 0\\.024141935117196405\ \(0\)\
\-\ laboratory\\:\\ 0\\.02389897570276037\ \(0\)\
\-\ later\\:\\ 0\\.02355270578666816\ \(0\)\
\-\ obtained\\:\\ 0\\.02327922172147713\ \(0\)\
\-\ wbc\\:\\ 0\\.023261442251311434\ \(0\)\
\-\ new\\:\\ 0\\.022768318784059507\ \(0\)\
\-\ thickening\\:\\ 0\\.022389859624786457\ \(0\)\
\-\ followed\\:\\ 0\\.022224362570886107\ \(0\)\
\-\ initial\\:\\ 0\\.022077922386980853\ \(0\)\
\-\ central\\:\\ 0\\.021977581883905122\ \(0\)\
\-\ revealed\\:\\ 0\\.021579532099686816\ \(0\)\
\-\ further\\:\\ 0\\.021435452492999964\ \(0\)\
\-\ no\\:\\ 0\\.021404531561403626\ \(0\)\
\-\ between\\:\\ 0\\.02138393935164874\ \(0\)\
\-\ clinical\\:\\ 0\\.020857411669399323\ \(0\)\
\-\ pulmonary\\:\\ 0\\.02006073999709061\ \(0\)\
\-\ when\\:\\ 0\\.01988011689267469\ \(0\)\
\-\ on\\:\\ 0\\.019879342361790987\ \(0\)\
\-\ abnormal\\:\\ 0\\.019772456824670572\ \(0\)\
\-\ secondary\\:\\ 0\\.0195071487716984\ \(0\)\
\-\ performed\\:\\ 0\\.019470224271243848\ \(0\)\
\-\ 10\\:\\ 0\\.019244650837294573\ \(0\)\
\-\ been\\:\\ 0\\.019174291020130043\ \(0\)\
\-\ significant\\:\\ 0\\.019002056334373338\ \(0\)\
\-\ cyst\\:\\ 0\\.018985112317780824\ \(0\)\
\-\ high\\:\\ 0\\.01870442644054685\ \(0\)\
\-\ prior\\:\\ 0\\.01841373318249508\ \(0\)\
\-\ anterior\\:\\ 0\\.018375550160911188\ \(0\)\
\-\ is\\:\\ 0\\.018025773373261417\ \(0\)\
\-\ consistent\\:\\ 0\\.017845071467125623\ \(0\)\
\-\ increased\\:\\ 0\\.017796675695610727\ \(0\)\
\-\ bilateral\\:\\ 0\\.01768755786144475\ \(0\)\
\-\ upper\\:\\ 0\\.017587100880632117\ \(0\)\
\-\ noted\\:\\ 0\\.017449336400492187\ \(0\)\
\-\ case\\:\\ 0\\.016534102361330412\ \(0\)\
\-\ contrast\\:\\ 0\\.01599075764009108\ \(0\)\
\-\ male\\:\\ 0\\.014653220044199389\ \(0\)\
\-\ normal\\:\\ 0\\.0134373193610692\ \(0\)\
\-\ this\\:\\ 0\\.011308794384860458\ \(0\)\
\-\ year\\:\\ 0\\.010142506189462356\ \(0\)\
\-\ for\\:\\ 0\\.009975055735250992\ \(0\)\
\-\ old\\:\\ 0\\.009740316857530247\ \(0\)\
